Stocks
AbbVie (ABBV) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 41.5% | 15.2% | 47.1% | 45.8% | 33.3% | 32.8% | ||
| Changes by years, y/y, % | +17pp | -26pp | +32pp | -1pp | -12pp | +6.0% | |||
AbbVie. EBITDA margin, %
AbbVie. EBITDA margin, changes, pp
AbbVie (ABBV) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | 48.8% | 17.5% | 29.2% | 45.7% | 41.1% | 32.8% | |
| Changes by years, y/y, % | +12pp | -28pp | -21pp | +6pp | +1pp | |||
| Changes by quarters, q/q, % | +9pp | -31pp | +12pp | +16pp | -5pp | |||
